English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community
Patient Daily | May 18, 2023

Zynex Announces Update Regarding Previously Announced Offerings

Patient Daily | May 18, 2023

Zynex Prices Upsized $52.5 Million Convertible Senior Notes Offering

Pacient Daily | May 18, 2023

How OR Automation Keeps Surgeons Busy (and Revenues Up)

Patient Daily | May 18, 2023

Sotera Health Reports First-Quarter 2023 Results

Patient Daily Report | May 18, 2023

NYU Langone Health professor: 'This study is the first collaboration of this focus and scale to find that adults with sleep apnea are at greater risk for long COVID'

Patient Daily Report | May 17, 2023

DBV Technologies CEO: 'We are thrilled to see the EPITOPE Phase 3 data published in the New England Journal of Medicine'

Patient Daily Report | May 16, 2023

Oxford professor on IVF procedure to prevent inheritable diseases: 'So far, the clinical experience with mitochondrial replacement therapy has been encouraging'

Patient Daily Report | May 15, 2023

Perrigo VP: 'Today's vote reflects the strong data showing that Opill® can be used safely and effectively over the counter'

Trending

Patient Daily | Aug 18, 2025

Medfluence Advisors’ Greg Caesar to open ASCENT 2025 with keynote on digital practice growth

Patient Daily | Aug 21, 2025

SoCal Breathe Free doctor on balloon sinuplasty: ‘The procedure itself is pretty quick and effectiveness is pretty high’

Patient Daily | Aug 21, 2025

Otolaryngologist on sinusitis and tooth pain: ‘Inflammation in the bottom of the sinus can cause sensitivity in the teeth’

+ Pharmaceuticals
Patient Daily | Aug 21, 2025

PhRMA director of public affairs on 340B rebate model: "Positive first step toward addressing hospital abuse of the 340B program

  • « First
  • «
  • 1
  • 2
  • 3
  • 4
  • 5
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2025 Patient Daily